HEADER    VIRAL PROTEIN                           31-DEC-69   7E3L
TITLE     Ultrapotent SARS-CoV-2 neutralizing antibodies with protective
TITLE   2 efficacy against newly emerged mutational variants
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: Spike glycoprotein;
COMPND   3 CHAIN: A, B, C;
COMPND   4 MUTATION: YES;
COMPND   5 ENGINEERED: YES;
EXPDTA     ELECTRON MICROSCOPY
REMARK 465 MISSING RESIDUES                                                    
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                      
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN              
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)               
REMARK 465
REMARK 465   M RES C SSSEQI  
REMARK 465     ALA C    67
REMARK 465     ILE C    68
REMARK 465     HIS C    69
REMARK 465     VAL C    70
REMARK 465     SER C    71
REMARK 465     GLY C    72
REMARK 465     THR C    73
REMARK 465     ASN C    74
REMARK 465     GLY C    75
REMARK 465     THR C    76
REMARK 465     LYS C    77
REMARK 465     ARG C    78
REMARK 465     PHE C    79
REMARK 465     ASP C    80
REMARK 465     GLN C   173
REMARK 465     PRO C   174
REMARK 465     PHE C   175
REMARK 465     LEU C   176
REMARK 465     MET C   177
REMARK 465     ASP C   178
REMARK 465     LEU C   179
REMARK 465     GLU C   180
REMARK 465     GLY C   181
REMARK 465     LYS C   182
REMARK 465     GLN C   183
REMARK 465     GLY C   184
REMARK 465     ASN C   185
REMARK 465     ILE C   197
REMARK 465     ASP C   198
REMARK 465     GLY C   199
REMARK 465     LEU C   212
REMARK 465     VAL C   213
REMARK 465     ARG C   214
DBREF  7E3L C    1  1208  UNP    P0DTC2   SPIKE_SARS2      1   1208
SEQRES   1 C  114  ALA TYR THR ASN SER PHE THR ARG GLY VAL TYR TYR PRO
SEQRES   2 C  114  ASP LYS VAL PHE ARG SER SER VAL LEU HIS SER THR GLN
SEQRES   3 C  114  ASP LEU PHE LEU PRO PHE PHE SER ASN VAL THR TRP PHE
SEQRES   4 C  114  HIS ALA ILE HIS VAL SER GLY THR ASN GLY THR LYS ARG
SEQRES   5 C  114  PHE ASP ASN PRO VAL LEU PRO PHE ASN ASP GLY VAL TYR
SEQRES   6 C  114  PHE ALA SER THR GLU LYS SER ASN ILE ILE ARG GLY TRP
SEQRES   7 C  114  ILE PHE GLY THR THR LEU ASP SER LYS THR GLN SER LEU
SEQRES   8 C  114  LEU ILE VAL ASN ASN ALA THR ASN VAL VAL ILE LYS VAL
SEQRES   9 C  114  CYS GLU PHE GLN PHE CYS ASN ASP PRO PHE            
SEQRES   1 C   79  ASN ASN CYS THR PHE GLU TYR VAL SER GLN PRO PHE LEU
SEQRES   2 C   79  MET ASP LEU GLU GLY LYS GLN GLY ASN PHE LYS ASN LEU
SEQRES   3 C   79  ARG GLU PHE VAL PHE LYS ASN ILE ASP GLY TYR PHE LYS
SEQRES   4 C   79  ILE TYR SER LYS HIS THR PRO ILE ASN LEU VAL ARG ASP
SEQRES   5 C   79  LEU PRO GLN GLY PHE SER ALA LEU GLU PRO LEU VAL ASP
SEQRES   6 C   79  LEU PRO ILE GLY ILE ASN ILE THR ARG PHE GLN THR LEU
SEQRES   7 C   79  LEU                                                
SEQRES   1 C   46  ALA ALA TYR TYR VAL GLY TYR LEU GLN PRO ARG THR PHE
SEQRES   2 C   46  LEU LEU LYS TYR ASN GLU ASN GLY THR ILE THR ASP ALA
SEQRES   3 C   46  VAL ASP CYS ALA LEU ASP PRO LEU SER GLU THR LYS CYS
SEQRES   4 C   46  THR LEU LYS SER PHE THR VAL